| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Atherosclerosis (peripheral vessels)Cilostazole| 1 | 2008 | Management of peripheral arterial disease in the elderly: focus on cilostazol. | 
| + | - | nl | Clin Interv Aging 3(1):17-23 (2008) |
| 2 | 2001 | Cilostazol (pletal): a dual inhibitor of cyclic nucleotide phosphodiesterase type 3 and adenosine uptake. | 
| + | - | nl | Cardiovasc Drug Rev 19(4):369-86 (2001) |
| 3 | 2008 | Safety and efficacy of cilostazol in the management of intermittent claudication. | 
| + | - | nl | Vasc Health Risk Manag 4(6):1197-203 (2008) |
| 4 | 2006 | The vascular effects of cilostazol. | 
| + | - | nl | Can J Cardiol 22 Suppl B(-):56B-60B (2006) |
| 5 | 2006 | Cilostazol, a phosphodiesterase III inhibitor: future perspectives in atherosclerosis. | 
| + | - | nl | Arq Bras Cardiol 87(5):e222-6 (2006) |